NCT05354596View on ClinicalTrials.gov

A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).

NARecruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 30, 2025

Study Completion Date

May 1, 2033

Conditions
Lung CancerMetastases to LungRadiotherapy Side Effect
Interventions
PROCEDURE

STRICT LUNG

Stereotactic body radiation therapy: Centrally located tumors are treated on standard-linacs with daily CBCT image-guidance and plan adaptation.

PROCEDURE

STAR LUNG

Stereotactic body radiation therapy: Ultra-centrally tumors are treated on MR-linacs with daily MR-guided plan-adaptation.

Trial Locations (6)

2100

RECRUITING

Rigshospitalet, Copenhagen

2730

RECRUITING

Herlev University Hospital, Herlev

5000

RECRUITING

Odense University Hospital, Odense

7100

RECRUITING

Department of Oncology, Lillebaelt Hospital, Vejle

8200

RECRUITING

Aarhus University Hospital, Aarhus

9100

NOT_YET_RECRUITING

Aalborg University Hospital, Aalborg

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Vejle Hospital

OTHER

collaborator

University of Copenhagen

OTHER

collaborator

Aalborg University Hospital

OTHER

lead

Rigshospitalet, Denmark

OTHER